Yatharth Hospital & Trauma Care Services liquidity ratios

·Pharma & HealthChart ›
ProfitabilityGrowthCreditLiquidityWorking capitalDividend yieldDuPontCAGR
Per cent unless marked ×
Tap a line for its trendLast 12Mto Jun 2026FY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023
13.47×————
3.87×3.87×10.12×7.59×1.77×
3.76×3.76×9.87×7.47×1.71×
22122143611337.4
52852877144376.7
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

YATHARTH₹923.30

Yatharth Hospital & Trauma Care Services Ltd.

· Pharma & Health
₹ CrorePeersMAXHEALTHMEDANTAFORTISVIYASHTHYROCARESUPRIYASTARSPARCMcap ₹8,896 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Altman Z-Score (Other Equity as RE)————13.47
Current Ratio1.777.5910.123.873.87
Quick Ratio1.717.479.873.763.76
Cash, Equiv & ST Investments37.4112.7435.9221.1221.1
Working Capital76.7443.0771.2528.1528.1
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.